Now loading...
ICICI Securities maintains a buy call on Archean Chemical Industries, setting a target price of Rs 675. The brokerage anticipates substantial revenue growth, projecting a 39% CAGR to Rs 20 billion by FY27, driven by increased bromine derivative and salt volumes. Undemanding valuations and strong financial forecasts support the positive outlook, despite potential risks like bromine demand weakness.
Now loading...